Dermatomyositis Not Yet Recruiting Phase 2 Trials for Basiliximab (DB00074)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03192657Basiliximab Treating Interstitial Pneumonia of CADMTreatment